Pasithea Therapeutics Corp（KTTA, KTTAW）美股招股说明书 S-1 （2025-11-18首版）（英文版）（48页）.pdf

1、S-1 1 ea0266093-s1_pasithea.htm REGISTRATION STATEMENTAs filed with the Securities and Exchange Commission on November 18,2025Registration No.333-UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM S-1REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PASITHEA THERAPEUTICS

2、 CORP.(Exact name of registrant as specified in its charter)Delaware 001-40804 85-1591963(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)1111 Lincoln Road,Suite 500Miami Beach,Florida 33139Telephone

3、:(786)977-3380(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Tiago Reis MarquesChief Executive Officer1111 Lincoln Road,Suite 500Miami Beach,Florida 33139(786)977-3380(Name,address,including zip code,and telephone number,including area

4、 code,of agent for service)Please send copies of all communications to:James OGrady,Esq.Lowenstein Sandler LLP1251 Avenue of the AmericasNew York,New York 10020Telephone:(212)262-6700Rakesh Gopalan,Esq.David S.Wolpa,Esq.Troutman Pepper Locke LLP301 S.College Street,Suite 3400Charlotte,North Carolina

5、 28202Telephone:(704)998-4050 Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this registration statement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415

6、underthe Securities Act of 1933,check the following box:If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please checkthe following box and list the Securities Act registration statement number of the earlier effective registratio